11:56 AM EST, 11/04/2025 (MT Newswires) -- Healwell AI (AIDX.TO) this week announced three transactions and dispositions, including Bio Pharma Services/CPO, interest in Mutuo Health and Polyclinic for up-front cash proceeds of $9.4 million. The assets were retained within the Well group of companies.

The transactions streamline HealWELL's business, now comprising a ~$120 million revenue run-rate with ~10% attributed to AI/data science and ~90%, healthcare software, mostly reflecting Orion, writes Stifel Canada analyst Justin Keywood.

He expects Healwell will generate $100 million in revenue in 2025, increasing to $125 million in 2026.

"The relatively small dispositions help simplify the story, removing certain services aspects (implied improved margins) and highlights a pure-play healthcare software and AI play with positive valuation implications."

Healwell has a Buy rating and $3.80 price target.

Price: 1.42, Change: -0.03, Percent Change: -2.07